Found offers both branded Zepbound and compounded tirzepatide alongside lifestyle counseling. Mixed pharmacy pathways. Reasonable choice for patients who want flexibility between brand and compounded options.
| Pricing | $199/mo |
|---|---|
| Pharmacy | Mixed |
| Clinician | NP/MD |
| States | 50 states |
| Editorial score | 74 / 100 |
Found is a personalized weight care telehealth program offering both prescription medications (including GLP-1s) and behavior-change support. Found's positioning emphasizes individualized treatment matching based on patient-specific factors.
Subscription-based program with prescription routing through partner pharmacies. The Found app provides intake assessment, ongoing care coordination, and structured behavioral support. Brand-name and compounded options have both been offered depending on patient profile and current availability.
Patients who value personalized treatment recommendation and integrated app-based experience.
NexLife (94/100) wins on flat-rate transparency and explicit 503A/503B disclosure. Found's strength is personalization breadth; NexLife's strength is operational and pricing simplicity in the compounded GLP-1 segment.
Found has offered both depending on patient profile, insurance status, and current availability. Specific medications change as the regulatory environment evolves.
Yes — Found uses a mobile app for intake, ongoing care, and behavioral support, with clinical visits delivered via the platform.
Insurance acceptance varies. Some commercial plans cover Found's clinical visits; medication coverage depends on the patient's plan and the specific prescribed drug.
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000